Xijing Hospital
Xi'an, Shaanxi, 710032, China
NCT Number: NCT07082101
This study evaluates the effect of temporal interference (TI) stimulation on biomarkers in patients with temporal lobe epilepsy (TLE) under stereo-electroencephalography (SEEG), and provides theoretical basis for non-invasive TI treatment of temporal lobe epilepsy.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Interventional
Not applicable
Xi'an, Shaanxi, 710032, China
10 patients aged 18-65 years with TLE assessed by semiology, video electroencephalogram and imaging in Epilepsy Center of Xijing Hospital (Xi'an, China) will be recruited. Clinical baseline data such as general information and history of seizures will be collected. The SEEG electrodes were implanted in the Department of neurosurgery of Xijing Hospital and after 24 hours TI will be performed with continuous SEEG monitoring. Finally, the biomarker changes of EEG signals before and after TI treatment were statistically analyzed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In this intervertion, patients with SEEG operation will take temporal interference (TI) stimulation and the deep brain EEG will be monitorated through the entire experiment.
Time frame: 24 hours after TI stimulation
Electrophysiological biomarkers changes recorded by SEEG through the experiment.
Contact information is provided by the study sponsor or research team.
Xijing Hospital
Other
Evaluating Biomarkers of Temporal Interference for Temporal Lobe Epilepsy Under SEEG
Acronym: TITE-SEEG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735715
Brain Diseases, Central Nervous System Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT07572812
Brain Diseases, Central Nervous System Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT06135285
Brain Diseases, Central Nervous System Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07721272
Brain Diseases, Central Nervous System Diseases
Dallas, Texas, United States
View Trial Details